Abstract
Abstract The development of an accurate and rapid method to measure parathyroid hormone (PTH) utilizing a two-site immunochemiluminometric assay (ICMA) has expanded its use to point-of-care testing. Measuring parathyroid hormone can be utilized to determine the completeness of parathyroid resection, to regionalize hypersecreting parathyroid glands, to identify parathyroid glands on fine-needle aspiration, and as a predictor of postoperative hypocalcemia following thyroidectomy and parathyroidectomy. This review addresses the current utilization of these techniques in patients with thyroid and parathyroid disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
